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 2 
ABSTRACT 1 
Background: Forearm fractures affect 1.7 million individuals worldwide each year and most 2 
occur earlier in life than hip fractures. While the heritability of forearm bone mineral density 3 
(BMD) and fracture is high, their genetic determinants are largely unknown.  4 
Aim: To identify genetic variants associated with forearm BMD and forearm fractures. 5 
Methods: BMD at distal radius measured by dual-energy X-ray absorptiometry was tested for 6 
association with common genetic variants. We conducted a meta-analysis of genome-wide 7 
association studies for BMD in 5,866 subjects of European descent and then selected variants for 8 
replication in 715 Mexican American samples. Gene-based association was carried out to 9 
supplement the single-SNP test. We then tested the BMD-associated SNPs for association with 10 
forearm fracture in 2,023 cases and 3,740 controls. 11 
Results: We found that five SNPs in the introns of MEF2C were associated with forearm BMD at 12 
a genome-wide significance level (P<5x10
-8
) in meta-analysis (lead SNP, rs11951031[T] -0.20 13 
standard deviations per allele, P=9.01x10
-9
). The gene-based association test suggested an 14 
association between MEF2C and forearm BMD (P=0.003). The association between MEF2C 15 
variants and risk of fracture did not achieve statistical significance (SNP rs12521522[A]: odds 16 
ratio = 1.14 [95% CI: 0.92-1.35], P = 0.14). Meta analysis also revealed two genome-wide 17 
suggestive loci at CTNNA2 and 6q23.2. 18 
Conclusion: These findings demonstrate that variants at MEF2C were associated with forearm 19 
BMD thereby implicating this gene in the determination of bone mineral density at forearm. 20 
 21 
Keywords: Genome-wide association study; Osteoporosis; Bone mineral density; Forearm; 22 
Fracture; Meta-analysis; Gene-base; Conditional analysis. 23 
  24 
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 3 
INTRODUCTION 1 
Osteoporosis is a common disease characterized by low bone mineral density (BMD), resulting in 2 
an increased risk of fragility fracture[1]. BMD, the best clinical indicator of fracture risk, is a highly 3 
heritable trait, with heritability estimates of 60%–85%[2]. Forearm fractures are among the most 4 
common fractures, affecting 1.7 million individuals per year[3], and have heritability of 54%[4].  5 
 6 
Genome-wide association studies (GWAS) have identified more than 10 genes associated with 7 
BMD from the Wnt signaling pathway, which is crucial to bone biology[5, 6]. We recently 8 
conducted two separate GWAS meta-analyses for cortical bone thickness and forearm BMD, and 9 
reported WNT16, which encodes an important Wnt factor, to be associated with BMD, cortical 10 
bone thickness, bone strength and osteoporotic fracture risk[7]. In the current study, we extended 11 
our study on forearm BMD by adding an additional GWAS cohort with BMD data, increasing our 12 
meta-analysis sample size for six GWAS cohorts to 5,866 European-descended samples. In this 13 
new analysis we detected an additional locus associated with forearm BMD and then replicated 14 
the association in an independent cohort comprising 715 Mexican American samples. We 15 
additionally conducted a gene-based association test to more fully characterize association 16 
signals from the meta-analysis. Finally, we selected the most compelling SNPs from these 17 
analyses and genotyped them in three cohorts comprising 2,023 forearm fracture cases and 18 
3,740 controls to test their effects on the risk of forearm fracture. 19 
 20 
MATERIALS AND METHODS 21 
The GWAS and fracture samples have been described previously[7]. Briefly, the six GWAS 22 
cohorts include the Amish Family Osteoporosis Study (AFOS), the Gothenburg Osteoporosis and 23 
Obesity Determinants (GOOD) study, the Anglo-Australasian Osteoporosis Genetics Consortium 24 
(AOGC) study, TwinsUK1, TwinsUK23 and TwinsUK4, comprising a total of 5,866 European-25 
descended samples. The TwinsUK4 cohort, which includes 194 subjects phenotyped for forearm 26 
BMD, was not included in our previous GWAS [7], nor was the Mexican American replication 27 
sample (see below). Genotyping of the TwinUK4 was done on the Illumina HumanHap650K 28 
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 4 
platform. The quality control criteria are similar to TwinsUK23 described in Zheng et al [7]. 1 
Imputation was performed using the IMPUTE2 [8] based on HapMap2, release 22. BMD at distal 2 
radius was measured in all cohorts by dual-energy X-ray absorptiometry following standard 3 
manufacturer protocols. The fracture cohorts include AOGC, the Umea Fracture and 4 
Osteoporosis (UFO) study, the Canadian Multi-Centre Osteoporosis study (CaMos) and the 5 
Manitoba-McGill (ManMc) fracture study, comprising 2,023 forearm fracture cases and 3,740 6 
controls. Forearm fracture was defined as fractures resulting from low trauma (such as a fall from 7 
standing height) occurring at the wrist, ulna, radius, and forearm, as well as Colles’ fractures. 8 
There are no overlapping samples between BMD and fracture. De-novo genotyping of SNP 9 
rs12521522 in fracture cases and controls was undertaken at Kbiosciences (England). All study 10 
participants provided informed written consent. Approval by local institutional review boards was 11 
obtained in all studies. 12 
 13 
 14 
The replication cohort is from the San Antonio Family Osteoporosis Study (SAFOS), which was 15 
designed as a study of cardiovascular and bone health in a representative sample of 16 
multigenerational Mexican American families[9]. Probands aged 40-60 years of age were 17 
recruited from low-income neighborhoods in San Antonio, Texas regardless of health status. The 18 
SAFOS samples were genotyped using the Illumina 550 HumanHap Beadchip by the Texas 19 
Biomedical Research Institute as part of the San Antonio Family Heart Study. Association 20 
analysis was conducted using the SOLAR software program[10] to account for family structure.  21 
To minimize the risk of false associations due to stratification in this admixed sample, we 22 
performed a principal component analysis using ~ one million genotypes to capture the total 23 
genetic variation in the sample as previously described [11].  We then included as covariates into 24 
the association analysis the first four principal components. A total of 715 samples with forearm 25 
BMD data were analyzed in the current study; the mean age, height and weight of these study 26 
subjects was 42 ± 14.7 (year), 161.9 ± 9.2 (centimeter) and 81.6 ± 21.5 (kilogram), respectively. 27 
 28 
Statistical methods for the meta-analysis were similar to those used in the previous analysis[7]. 29 
Page 4 of 18
http://mc.manuscriptcentral.com/jmedgenet





























































Confidential: For Review Only
 5 
Briefly, all cohorts independently conducted the association analysis of SNP allele dosage with 1 
standardized BMD residuals, while adjusting for age, age2, gender, height, weight and population 2 
substructure where applicable, for center of recruitment (AOGC), and for family structure in 3 
cohorts with family members. A meta-analysis of the GWAS results was conducted using the 4 
GWAMA software (Genome-Wide Association Meta Analysis) 5 
(http://www.well.ox.ac.uk/gwama/)[12] with fixed-effects inverse variance meta-analysis[13].  6 
 7 
We next performed a gene-based association test following the procedure proposed by Liu et al 8 
as implemented in the software VEGAS[14], a computationally feasible method for analyzing 9 
meta-analytic results. We included all SNPs within genes (including ±50 kb from the 5’ and 3’ 10 
UTR) with a maximum of 1x106 simulations to account for the linkage disequilibrium (LD) 11 
structure among SNPs within a gene. Conditional analysis was conducted using GCTA 12 
0.93.9[15], an approximate conditional analysis method using summary-level statistics from the 13 
meta-analysis and LD corrections between SNPs estimated from a reference sample[16]. We 14 
used TwinsUK23 as the reference sample to calculate the LD information of SNPs, due to its 15 
size.  16 
 17 
SNPs that were associated with BMD were assessed for association with fracture risk using 18 
logistic regression models adjusted for age, gender, height and weight. We used CatS[17] for 19 
power calculation. 20 
 21 
RESULTS 22 
GWAS analyses were performed in the six cohorts for forearm BMD applying cohort-specific 23 
genomic controls. The cohort-specific results were meta-analyzed using fixed effects meta-24 
analysis, again applying the overall meta-analytic genomic control (Overall λ = 1.012, and 1.051 25 
for AFOS; 0.990 for AOGC; 1.014 for GOOD; 1.0089 for TwinsUK1; 1.0037 for TwinsUK23; 1.170 26 
for TwinsUK4). A quantile-quantile plot of the observed P values showed a clear deviation at the 27 
tail of the distribution from the null distribution (the distribution expected if there were no 28 
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 6 
association) even after 648 SNPs were removed from the WNT16 region, which was reported 1 
previously [7]. This suggests that the observed P values, particularly the ones within the tail of the 2 
distribution, are smaller than those expected by chance and probably reflect true genetic 3 
association (Supplementary Figure S1). 4 
 5 
Genome-wide associations with forearm BMD were observed at two loci, WNT16 (7q31) and 6 
MEF2C (5q14.3). At WNT16, significant associations were observed with 30 SNPs (3.26x10-7 
8>P>1.87x10-13), replicating an association we have previously observed [7] (Supplementary 8 
Figure S2).  At MEF2C, five of eight SNPs were significantly associated with forearm BMD, with 9 
the other three SNPs showing suggestive levels of association (4.55x10-7 >P>3.15x10-8) on meta-10 
analysis (Supplementary Figure S2 and Figure 1). The most significantly associated SNP was 11 
rs12521522 (-0.20 standard deviations [SD] per A allele, P = 3.15x10-8) (Table1). These eight 12 
SNPs were highly correlated with each other (HapMap CEU LD calculation: 1> R2 >0.85). Using 13 
association results from the GWAS meta-analysis we next sought to determine if there were any 14 
gene-based signals arising when GWAS summary statistics were collapsed across the genes 15 
[14]; The gene-based test results support the single-SNP findings of the meta-analysis, with 16 
collapsing P-values of 0.003 for gene MEF2C. 17 
 18 
Meta analysis also revealed two genome-wide suggestive loci at CTNNA2 and 6q23.2, including 19 
34 genome-wide suggestive SNPs in the region of CTNNA2 (1.73x10-6<P<5x10-6) and 10 20 
genome-wide suggestive SNPs at 6q23.2 (5.52x10-7<P<3.76x10-6) (Supplementary Figure S2). 21 
 22 
We attempted an in silico replication on the eight SNPs associated with forearm BMD at MEF2C 23 
in the Mexican American population. Four of the eight SNPs were monomorphic in the replication 24 
population. Of the remaining four polymorphic SNPs, three had effect sizes in the same direction 25 
as, and even slightly larger than, those observed in the meta-analysis, including two SNPs for 26 
which the associations in Mexican Americans achieved statistical significance at the 0.05 27 
threshold (rs12522630 and rs17494872) (Table 1). In the joint analysis of discovery and 28 
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 7 
replication populations, evidence of association improved for the three SNPs, with the most 1 
significant association at rs11951031 (-0.20 SD per T allele, P = 9.01x10-9) (Table 1 and Figure 2 
2). 3 
 4 
In order to investigate whether the variants showing association with forearm BMD also have an 5 
effect on the risk of forearm fracture, we tested SNP rs12521522 for de novo genotyping in 6 
samples with forearm fracture and their controls. In the meta-analysis for fracture, comprising 7 
2,023 forearm fracture cases and 3,740 controls, from 3 cohorts. The association between 8 
rs12521522 and risk of fracture did not achieve statistical significance (Odds Ratio [OR] = 1.14 9 
[95% CI: 0.92-1.35], P = 0.14) (Table 1). The fracture associations for the other 7 SNPs at the 10 
MEF2C locus were tested in silico in the much smaller AOGC fracture GWAS cohort in 155 cases 11 
and 1672 controls and the results showed no evidence of association (Table 1). 12 
 13 
Because SNP rs1366594, which locates upstream of MEF2C gene (Figure 1), has been 14 
previously reported to be associated with femoral neck (FN) BMD [18], we evaluated whether this 15 
SNP or signals from this region could explain the observed association with forearm BMD. First, 16 
the minor allele frequency (MAF) of forearm BMD-associated SNP in our study (rs11951031, 17 
MAF=0.06) was considerably lower than that of FN BMD-associated SNP (rs1366594, 18 
MAF=0.45), and the effect size of rs11951031 (-0.20 SD per T allele) was much larger than 19 
rs1366594 (−0.085 SD per C allele). Second, these two SNPs are only very weakly correlated 20 
with each other (HapMap CEU LD calculation: R-square =0.087). Third, after conditioning on the 21 
effect of rs1366594, the effect size for rs11951031 on forearm BMD decreased from -0.20 SD per 22 
T allele (4.16x10-8) to -0.18 SD per T allele (1.35x10-6). Therefore, the SNPs we have found to be 23 
associated with forearm BMD are distinct from those found previously [18]. 24 
 25 
DISCUSSION 26 
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 8 
We identified gene MEF2C, a member of the Wnt signaling pathway, to be associated with 1 
forearm BMD in meta-analysis in a collection of 6,584 individuals. In addition, we observed a non-2 
significant trend towards risk of fracture at this locus. 3 
 4 
The Wnt/β-catenin signaling pathway is known to play an important role in the regulation of bone 5 
mass and bone turnover[19]. MEF2C is an important member of this pathway[5, 6], and, in fact, in 6 
the large GEFOS Consortium, a SNP (rs1366594) located upstream from this gene, was 7 
associated with FN BMD, although not with lumbar spine BMD[18], We report in this study that 8 
intronic variants in MEF2C are associated with forearm BMD, a clinically distinct phenotype from 9 
that at femoral neck. 10 
 11 
Our finding adds three novel pieces to the genetics of BMD puzzle. First, bone at the forearm is 12 
structurally different than bone at the femoral neck insofar as forearm bone contains a much 13 
higher proportion of cortical bone. BMD at both sites predicts fracture at their respective 14 
anatomical sites better than at other sites. Second, the associated variants for forearm BMD 15 
appear to be quite distinct from the variants associated with FN BMD. Not only are they located 16 
over ~237kb from each other (Figure 1), but they have very different allele frequencies (0.06 vs 17 
0.45) and very different effect sizes (-0.20 SD vs -0.06 SD), and they are not correlated. 18 
Moreover, conditional analyses reveal that the effect of rs11951031 on forearm BMD are largely 19 
independent of any effect of rs1366594. We postulate that these common variants are likely 20 
independent signals that have different independent effects on the two BMD phenotypes. It is 21 
also possible that both associations arise from several rare causal variants on the same 22 
haplotype background [20], however, this hypothesis will likely be tested as more sequencing 23 
studies emerge for BMD. These observations also suggest that the same variants have 24 
differential effects on different types of bone. 25 
 26 
We did not observe a statistically significant association of MEF2C SNP (rs12521522) with 27 
osteoporotic fracture in the current study. Our sample size (2,023 cases and 3,740 controls) 28 
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 9 
provided 44% power to detect an odds ratio of 1.14 for a risk allele having a frequency of 0.06. 1 
However, the direction of effect of the alleles that decreased BMD was associated with in 2 
increase in fracture risk across the study cohorts. Given the sample size for fracture in this study, 3 
these results should be interpreted cautiously and require further replication. Additionally, 4 
rs1366594, which was reported in Rivadeneira et al [18] showed no evidence of association with 5 
forearm fracture neither in the AOGC in silico analysis (155 cases and 1672 controls, P=0.27).  6 
 7 
 8 
In summary, our data provides first evidence that intronic variants at the MEF2C locus, a member 9 
of the Wnt pathway, are associated with forearm BMD. These findings expand our understanding 10 
of the genetic determinants of forearm BMD, a clinically relevant skeletal site. 11 
 12 
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Figure legend: 1 
Figure 1. Scatter plots of the observed association with forearm BMD in the 800kb wide region around 2 
rs12521522 in MEF2C locus. The P values of SNPs (shown as –log10 values in y-axis, from the genome-3 
wide single-marker association analysis using the linear regression model) are plotted against their map 4 
position (b36) (x-axis). The color of each SNP spot reflects its r2 with rs12521522. SNPs rs11951031 and 5 
rs12521522 are in perfect LD, and rs1366594 is ~237kb away from rs11951031. 6 
 7 
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Table 1: Association results of forearm BMD meta-analysis and fracture of the top SNPs. 
 
EA: effect allele; NEA: non-effect allele; EAF: effect allele frequency;  
NA: not applicable; these SNPs were not polymorphic in Mexican Americans (rs17558256, rs12521522, rs11955542 and rs12515983). 
* Combined results of GWAS meta-analysis and SAFOS replication study. 
# SNP rs12521522 was tested in 2,023 cases and 3,740 controls; the other 7 SNPs were tested in 155 cases and 1672 controls. 
Boldface indicated the genome wide significant SNPs. 
 
GWAS Meta analysis SAFOS Joint analysis* Fracture analysis# 
CHR SNP POSITION EA NEA EAF BETA SE P EAF BETA SE P BETA SE P OR P 
5 rs17558256 88119209 C T 0.06 -0.20 0.04 3.15x10
-8
 0 NA NA NA NA NA NA 1.20 (0.82-1.43) 0.33 
5 rs11958689 88142609 G C 0.06 -0.20 0.04 4.16x10
-8
 0.08 0.04 0.11 0.72 -0.18 0.03 3.35x10
-7
 1.21 (0.83-1.45) 0.31 
5 rs12521522 88148517 A T 0.06 -0.20 0.04 3.15x10
-8
 0 NA NA NA NA NA NA 1.14 (0.92-1.35) 0.14 
5 rs11955542 88148984 T C 0.06 -0.20 0.04 3.15x10
-8
 0 NA NA NA NA NA NA 1.20 (0.82-1.43) 0.33 
5 rs11951031 88174487 T C 0.06 -0.20 0.04 4.16x10
-8
 0.04 -0.23 0.14 0.10 -0.20 0.04 9.01x10
-9
 1.20 (0.81-1.45) 0.33 
5 rs12515983 88189831 A T 0.06 -0.20 0.04 6.12x10
-8
 0 NA NA NA NA NA NA 1.19 (0.81-1.44) 0.34 
5 rs12522630 88224123 A G 0.07 -0.18 0.04 3.35x10
-7
 0.04 -0.29 0.14 0.04 -0.19 0.03 5.19x10
-8
 1.25 (0.83-1.49) 0.22 
5 rs17494872 88228915 A G 0.07 -0.18 0.04 4.55x10
-7
 0.04 -0.29 0.14 0.04 -0.19 0.03 6.82x10
-8
 1.25 (0.83-1.49) 0.23 
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Figure 1. Scatter plots of the observed association with forearm BMD in the 800kb wide region around 
rs12521522 in MEF2C locus. The P values of SNPs (shown as –log10 values in y-axis, from the genome-wide 
single-marker association analysis using the linear reg ession model) are plotted against their map position 
(b36) (x-axis). The color of each SNP spot reflects its r2 with rs12521522. SNPs rs11951031 and 
rs12521522 are in perfect LD, and rs1366594 is ~237kb away from rs11951031.  
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Figure 2. Forest plot of association of rs11951031 (effect allele T) with forearm BMD.  
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Supplementary	  Figure	  S1	  
Quantile-quantile plots of the observed P values versus the expected P values for association. The dots in 
blue were plotted on the entire set of SNPs, whereas the dots in red were obtained after removing WNT16 
region SNPs (+/- 400KB either side of rs2908004). The black line was the distribution expected if there 
were no association. 	  	  
Blue:	  all	  SNPs	  Red:	  exclude	  SNPs	  from	  WNT16	  region	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Supplementary	  Figure	  S2	  
Manhattan plot for GWAS Meta-Analysis of Forearm BMD. Genome-wide P values (−log10 P) of the 
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